Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04025060 · ClinicalTrials.gov registry record · NA
Reducing Sugar-sweetened Beverage Consumption Among Children
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT04025060 is a NA study that has completed, run by George Washington University. The registered enrollment target is 29 participants.
The verdict
NCT04025060, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Lowering sugar-sweetened beverage (SSB) consumption is a central component of lifestyle behavior change aimed at preventing and managing obesity, yet effective reduction of SSB intakes has been met with many challenges. While their palatability, accessibility, publicity, affordability, and social acceptability contribute to frequent and sustained SSB consumption, their caffeine and sugar content may further encourage continued intake. Although adverse health consequences of excessive SSB consumption are well documented, the extent to which their pleasant taste (due primarily to their sugar content) and post-ingestive effects (due to their sugar and/or caffeine content) positively reinforce consumption among children has not been elucidated. The purpose of this study is to conduct a pilot intervention to examine the feasibility of removing caffeinated SSBs from the child diet and to explore whether caffeinated SSB removal induces withdrawal symptoms in 8-11 (3rd-5th grade) year old children. Participants will be randomly assigned to replace their usual caffeinated SSB consumption with either caffeinated SSBs, caffeine-free SSBs or sparkling water provided by the study team for two weeks.
Interventions
- BEHAVIORAL Commercially-available caffeine-free soda
- BEHAVIORAL Carbonated water
- BEHAVIORAL Regular soda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2019-07-10 |
| Est. Completion | 2021-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04025060
The ClinicalTrials.gov registry entry for NCT04025060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Commercially-available caffeine-free soda is the first listed.
NCT04025060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04025060 about?
NCT04025060 is a clinical study titled "Reducing Sugar-sweetened Beverage Consumption Among Children". Lowering sugar-sweetened beverage (SSB) consumption is a central component of lifestyle behavior change aimed at preventing and managing obesity, yet effective reduction of SSB intakes has been met with many challenges. While their palatability, accessibility, publicity, affordability, and social ac...
What is the current status of trial NCT04025060?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2019-07-10. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT04025060?
The interventions under investigation include: Commercially-available caffeine-free soda (BEHAVIORAL), Carbonated water (BEHAVIORAL), Regular soda (BEHAVIORAL).
Who is sponsoring clinical trial NCT04025060?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.